Challenges Faced by Patients in Gout Treatment

From Medicine Service, Birmingham VA Medical Center; and Department of Medicine at School of Medicine and Division of Epidemiology at School of Public Health, University of Alabama, Birmingham, AL; and Department of Orthopedic Surgery, Mayo Clinic College of Medicine, Rochester, MN. This material is the result of work supported by research funds from the Division of Rheumatology at the University of Alabama at Birmingham and the resources and use of facilities at the Birmingham VA Medical Center, Birmingham, AL. J.A.S. is also supported by grants from the Agency for Health Quality and Research Center for Education and Research on Therapeutics; National Institute of Arthritis, Musculoskeletal and Skin Diseases; National Institute of Aging; and National Cancer Institute. J.A.S. has received research and travel grants from Takeda and Savient and consultant fees from Savient, Takeda, Regeneron and Allergan. J.A.S. is a member of the executive of OMERACT, an organization that develops outcome measures in rheumatology and receives arms-length funding from 36 companies; a member of the American College of Rheumatology's Guidelines Subcommittee of the Quality of Care Committee; and a member of the Veterans Affairs Rheumatology Field Advisory Committee. The University of Alabama at Birmingham's institutional review board approved this study, and all investigations were conducted in conformity with ethical principles of research. Correspondence: Jasvinder A. Singh, MBBS, MPH, University of Alabama, Faculty Office Tower 805B, 510 20th St S, Birmingham, AL 35294. E-mail: [email protected].